Results 281 to 290 of about 1,672,248 (364)

Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Myasthenia gravis (MG) clinical trials typically allow rescue therapy during follow‐up in the event of marked worsening of MG symptoms. Failure to appropriately address rescue therapy in defining treatment effects and planning statistical analyses may yield biased estimates, increase false positive rates, or decrease statistical power – all of
Justin M. Leach, Inmaculada Aban, Gary Cutter, Michael Benatar   +3 more
wiley   +1 more source

The role and function of lncRNA in ageing-associated liver diseases. [PDF]

RNA Biol
Zarandi PK, Ghiasi M, Heiat M.
europepmc   +1 more source

The Effect of Lipotropic Substances Especially Choline on Liver Kidney Disease Produced by Diet (I)

, 1958
Könosuke Tomabechi
openalex   +2 more sources

Liver transplantation and portacaval shunt in genetic diseases [PDF]

, 1982
Starzl, TE
core  

Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)

Annals of Clinical and Translational Neurology, EarlyView.
Abstract Background LGI1‐antibody encephalitis (LGI1‐Ab‐E) is a common form of autoimmune encephalitis where most patients demonstrate ‘good’ clinician‐rated outcomes. However, more targeted questionnaires reveal numerous debilitating symptoms for many years.
Mark J Kelly, Barbara Wagner, Bryan Ceronie, Christine Strippel, Ann Yee Lin, Adam Handel, John Soltys, Sophie Binks, Philip A Powell, Sarosh R Irani   +9 more
wiley   +1 more source

Biological and clinical role of TREM2 in liver diseases. [PDF]

Hepatol Commun
Ma K, Guo S, Li J, Wei T, Liang T.
europepmc   +1 more source

On the liver functions of patients suffering from heart, kindney and hypertensive diseases

, 1957
K. Kitahara, Shigeo Torizawa, M. Ito, J Kondo, Kentaro Hayashi, K Kanzaki, Katsutoshi Ishihara, Yuki Yamada   +7 more
openalex   +2 more sources

Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The hereditary spastic‐ataxia spectrum disorders are a group of disabling neurological diseases. The traditional genetic testing pathway is complex, multistep and leaves many cases unsolved. We aim to streamline and improve this process using long‐read sequencing. Methods We developed a targeted long‐read sequencing strategy with the
Laura Ivete Rudaks, Igor Stevanovski, Dennis Yeow, Andre L. M. Reis, Sanjog R. Chintalaphani, Pak Leng Cheong, Hasindu Gamaarachchi, Lisa Worgan, Kate Ahmad, Michael Hayes, Andrew Hannaford, Samuel Kim, Victor S. C. Fung, Gabor M. Halmagyi, Andrew Martin, David Manser, Michel Tchan, Karl Ng, Marina L. Kennerson, Ira W. Deveson, Kishore Raj Kumar   +20 more
wiley   +1 more source

A scheme to underpin key mediator(s) in Salinosporamide(s) against pan-tumor via systems biology concept

Journal of Translational Medicine
Ki-Kwang Oh, Sang-Jun Yoon, Seol Hee Song, Jeong Ha Park, Jeong Su Kim, Min Ju Kim, Dong Joon Kim, Ki-Tae Suk   +7 more
doaj   +1 more source

Metabolic Syndrome, Gastric Cancer Mortality and Competing Risk Survival Analysis

EBioMedicine, 2017
Mohamad Amin Pourhoseingholi, Sara Ashtari, Nastaran Hajizadeh, Mohammad Reza Zali   +3 more
doaj   +1 more source